These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8289137)

  • 1. A Weibull distribution model for intradermal administration of ceftazidime.
    Bressolle F; Laurelli JM; Gomeni R; Bechier JG; Wynn NR; Galtier M; Eledjam JJ
    J Pharm Sci; 1993 Nov; 82(11):1175-8. PubMed ID: 8289137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and distribution of ceftazidime to milk after intravenous and intramuscular administration to lactating female dromedary camels (Camelus dromedarius).
    Goudah AM; Hasabelnaby SM
    J Am Vet Med Assoc; 2013 Aug; 243(3):424-9. PubMed ID: 23865886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double Weibull input function describes the complex absorption of sustained-release oral sodium valproate.
    Bressolle F; Gomeni R; Alric R; Royer-Morrot MJ; Necciari J
    J Pharm Sci; 1994 Oct; 83(10):1461-4. PubMed ID: 7884670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
    Abd El-Aty AM; Goudah A; Abo El Sooud K
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats.
    Albarellos GA; Ambros LA; Landoni MF
    Vet J; 2008 Nov; 178(2):238-43. PubMed ID: 17768077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronokinetics of ceftazidime after intramuscular administration to dogs.
    Monfrinotti A; Ambros L; Montoya L; Prados AP; Rebuelto M
    Chronobiol Int; 2010 May; 27(3):549-59. PubMed ID: 20524800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic modelling to predict exposure differences in healthy volunteers and subjects with renal impairment: Ceftazidime case study.
    Zhou L; Tong X; Sharma P; Xu H; Al-Huniti N; Zhou D
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):100-107. PubMed ID: 30739396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ceftazidime in sheep and its penetration into tissue and peritoneal fluids.
    Rule R; Rubio M; Perelli MC
    Res Vet Sci; 1991 Nov; 51(3):233-8. PubMed ID: 1780573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ceftazidime administered to lactating and non-lactating goats.
    Rule R; Villagra S; Barrena P; Lacchini R; Reynaldi FJ
    J S Afr Vet Assoc; 2011 Dec; 82(4):219-23. PubMed ID: 22616435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients.
    Jonsson M; Walder M
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):15-21. PubMed ID: 1563378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ceftazidime in loggerhead sea turtles (Caretta caretta) after single intravenous and intramuscular injections.
    Stamper MA; Papich MG; Lewbart GA; May SB; Plummer DD; Stoskopf MK
    J Zoo Wildl Med; 1999 Mar; 30(1):32-5. PubMed ID: 10367641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ; Smith MD; Suputtamongkol Y; Mattie H; Walsh AL; Wuthiekanun V; Chaowagul W; White NJ
    Br J Clin Pharmacol; 2000 Aug; 50(2):184-91. PubMed ID: 10930972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers.
    Wise ER; Armstrong GC; Brown RM; Andrews JM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():277-82. PubMed ID: 19802998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hemodialysis on ceftazidime pharmacokinetics.
    Nikolaidis P; Tourkantonis A
    Clin Nephrol; 1985 Sep; 24(3):142-6. PubMed ID: 3899438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing age and acute infection influence the kinetics of ceftazidime.
    Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 1989; 21(3):327-32. PubMed ID: 2667099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of ceftazidime during hemodiafiltration in critically ill patients.
    Sato T; Okamoto K; Kitaura M; Kukita I; Kikuta K; Hamaguchi M
    Artif Organs; 1999 Feb; 23(2):143-5. PubMed ID: 10027883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profiles of ceftazidime in cochlear perilymph, cerebrospinal fluid and plasma: a high-performance liquid chromatographic study.
    Sun AH; Parnes LS; Freeman DJ
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):256-9. PubMed ID: 8587777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ; Smith MD; Suputtamongkol Y; Mattie H; Walsh AL; Wuthiekanun V; Chaowagul W; White NJ
    Br J Clin Pharmacol; 2000 May; 49(5):445-52. PubMed ID: 10792202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-related characteristics of ceftazidime pharmacokinetics in children].
    Prokhorenko PI; Strachunskiĭ LS; Andreenkova EG; Portnoĭ IuA; Firsov AA
    Antibiot Khimioter; 1992 Jun; 37(6):29-31. PubMed ID: 1417341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.